Cargando…
A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned
The Progression of Atrophy Secondary to Stargardt Disease (ProgStar) studies were designed to measure the progression of Stargardt disease through the use of fundus autofluorescence imaging, optical coherence tomography, and microperimetry. The overarching objectives of the studies were to document...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469878/ https://www.ncbi.nlm.nih.gov/pubmed/31019847 http://dx.doi.org/10.1167/tvst.8.2.16 |
_version_ | 1783411695388983296 |
---|---|
author | Ervin, Ann-Margret Strauss, Rupert W. Ahmed, Mohamed I. Birch, David Cheetham, Janet Ferris, Frederick L. Ip, Michael S. Jaffe, Glenn J. Maguire, Maureen G. Schönbach, Etienne M. Sadda, SriniVas R. West, Sheila K. Scholl, Hendrik P.N. |
author_facet | Ervin, Ann-Margret Strauss, Rupert W. Ahmed, Mohamed I. Birch, David Cheetham, Janet Ferris, Frederick L. Ip, Michael S. Jaffe, Glenn J. Maguire, Maureen G. Schönbach, Etienne M. Sadda, SriniVas R. West, Sheila K. Scholl, Hendrik P.N. |
author_sort | Ervin, Ann-Margret |
collection | PubMed |
description | The Progression of Atrophy Secondary to Stargardt Disease (ProgStar) studies were designed to measure the progression of Stargardt disease through the use of fundus autofluorescence imaging, optical coherence tomography, and microperimetry. The overarching objectives of the studies were to document the natural course of Stargardt disease and identify the most appropriate clinical outcome measures for clinical trials assessing the efficacy and safety of upcoming treatments for Stargardt disease. A workshop organized by the Foundation Fighting Blindness Clinical Research Institute was held on June 11, 2018, in Baltimore, MD, USA. Invited speakers discussed spectral-domain optical coherence tomography, fundus autofluorescence, and microperimetry methods and findings in the ProgStar prospective study. The workshop concluded with a panel discussion of optimal endpoints for measuring treatment efficacy in Stargardt disease. We summarize the workshop presentations in light of the most current literature on Stargardt disease and discuss potential clinical outcome measures and endpoints for future treatment trials. |
format | Online Article Text |
id | pubmed-6469878 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | The Association for Research in Vision and Ophthalmology |
record_format | MEDLINE/PubMed |
spelling | pubmed-64698782019-04-24 A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned Ervin, Ann-Margret Strauss, Rupert W. Ahmed, Mohamed I. Birch, David Cheetham, Janet Ferris, Frederick L. Ip, Michael S. Jaffe, Glenn J. Maguire, Maureen G. Schönbach, Etienne M. Sadda, SriniVas R. West, Sheila K. Scholl, Hendrik P.N. Transl Vis Sci Technol New Developments in Vision Research The Progression of Atrophy Secondary to Stargardt Disease (ProgStar) studies were designed to measure the progression of Stargardt disease through the use of fundus autofluorescence imaging, optical coherence tomography, and microperimetry. The overarching objectives of the studies were to document the natural course of Stargardt disease and identify the most appropriate clinical outcome measures for clinical trials assessing the efficacy and safety of upcoming treatments for Stargardt disease. A workshop organized by the Foundation Fighting Blindness Clinical Research Institute was held on June 11, 2018, in Baltimore, MD, USA. Invited speakers discussed spectral-domain optical coherence tomography, fundus autofluorescence, and microperimetry methods and findings in the ProgStar prospective study. The workshop concluded with a panel discussion of optimal endpoints for measuring treatment efficacy in Stargardt disease. We summarize the workshop presentations in light of the most current literature on Stargardt disease and discuss potential clinical outcome measures and endpoints for future treatment trials. The Association for Research in Vision and Ophthalmology 2019-04-12 /pmc/articles/PMC6469878/ /pubmed/31019847 http://dx.doi.org/10.1167/tvst.8.2.16 Text en Copyright 2019 The Authors http://creativecommons.org/licenses/by-nc-nd/4.0/ This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. |
spellingShingle | New Developments in Vision Research Ervin, Ann-Margret Strauss, Rupert W. Ahmed, Mohamed I. Birch, David Cheetham, Janet Ferris, Frederick L. Ip, Michael S. Jaffe, Glenn J. Maguire, Maureen G. Schönbach, Etienne M. Sadda, SriniVas R. West, Sheila K. Scholl, Hendrik P.N. A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned |
title | A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned |
title_full | A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned |
title_fullStr | A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned |
title_full_unstemmed | A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned |
title_short | A Workshop on Measuring the Progression of Atrophy Secondary to Stargardt Disease in the ProgStar Studies: Findings and Lessons Learned |
title_sort | workshop on measuring the progression of atrophy secondary to stargardt disease in the progstar studies: findings and lessons learned |
topic | New Developments in Vision Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6469878/ https://www.ncbi.nlm.nih.gov/pubmed/31019847 http://dx.doi.org/10.1167/tvst.8.2.16 |
work_keys_str_mv | AT ervinannmargret aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT straussrupertw aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT ahmedmohamedi aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT birchdavid aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT cheethamjanet aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT ferrisfrederickl aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT ipmichaels aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT jaffeglennj aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT maguiremaureeng aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT schonbachetiennem aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT saddasrinivasr aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT westsheilak aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT schollhendrikpn aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT aworkshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT ervinannmargret workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT straussrupertw workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT ahmedmohamedi workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT birchdavid workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT cheethamjanet workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT ferrisfrederickl workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT ipmichaels workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT jaffeglennj workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT maguiremaureeng workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT schonbachetiennem workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT saddasrinivasr workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT westsheilak workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT schollhendrikpn workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned AT workshoponmeasuringtheprogressionofatrophysecondarytostargardtdiseaseintheprogstarstudiesfindingsandlessonslearned |